Co-Chair of the Paul, Weiss Litigation Department, Liz Stotland Weiswasser leads teams handling complex competitor disputes for innovators across a variety of industries. Liz combines deep scientific fluency with litigation and trial excellence and business insight to help clients achieve strategic outcomes in high-stakes disputes. Clients note that Liz is “is incredibly perceptive, intelligent and practical” and “has deep knowledge of life sciences and patents, and has excellent client service and judgment.”
Liz is one of the foremost life sciences litigators in the country. She is lead counsel to some of the world’s most important pharmaceutical, biotechnology and medical device companies, and has extensive experience in both in federal courts and in inter partes and post-grant review proceedings before the U.S. Patent Office. She has led patent cases across the full range of biopharma technologies, including a wide variety of biologics, small molecules, formulation, drug delivery and methods of treatment. Liz also builds and leads teams in related areas of litigation in the life sciences industry, including in the antitrust and broader commercial areas. Liz’s experience, along with her deep training in molecular biology and biochemistry, has made her a highly sought-after litigator and counselor in the life sciences industry. Liz is licensed before the U.S. Patent Office and Patent Trial and Appeal Board, and is recognized as one of the leading patent practitioners. She previously served as a law clerk to Judge Alan D. Lourie of the U.S. Court of Appeals for the Federal Circuit.
Liz earned a B.A. in biochemistry and molecular biology from Northwestern University and did graduate work in molecular biology at Princeton University
